SBFM

Sunshine Biopharma Inc
1.05
-0.085 (-7.49%)

Sunshine Biopharma Inc. (SBFM) Fundamentals

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).
SHARE INFORMATION
Market Cap$ 25,634,692
Shares Outstanding22,585,632
Float22,226,798
Percent Float98.41%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 228,426
Latest Fiscal EPS$ -4.65
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions17
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months13,689
Institutional Holdings Percent3.5%
Institutional Sold Previous 3 Months571,376
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months30,000
Insider Holdings Percent0.8
Insider Sold Previous 3 Months-
Insider Shares Owned184,465
TRADING INFO
52 Week High$ 10.50
52 Week Low$ 0.04
52 Week High Change$ 2,362.57
21 Day Moving Average$ 1.01
21 Day Extended Moving Average$ 1.0335
50 Day Moving Average$ 0.84
50 Day Extended Moving Average$ 0.924088
200 Day Moving Average$ 1.1504
200 Day Extended Moving Average$ 1.0431
10 Day Average Volume267,571
20 Day Average Volume376,540
30 Day Average Volume307,810
50 Day Average Volume235,048
Alpha1.421260
Beta-12.7510
Standard Deviation5.242700
R20.017108
7 Day Price Change$ -0.095
7 Day Percent Change-7.72%
21 Day Price Change$ 0.2964
21 Day Percent Change35.34%
30 Day Price Change$ 0.4149
30 Day Percent Change57.62%
Month to Date Price Change$ -0.095
Month to Date Percent Change-7.72%
Quarter to Date Price Change$ 0.495
Quarter to Date Percent Change77.34%
180 Day Price Change$ -0.135
180 Day Percent Change-10.63%
200 Day Price Change$ 0.095
200 Day Percent Change9.13%
Year to Date Price Change$ 0.495
Year to Date Percent Change77.34%

Sunshine Biopharma Inc. (SBFM) Key Ratios

PROFITABILITY
EBIT Margin-512.5%
EBITDA Margin-510.5%
Pre-Tax Profit Margin-1,583.5%
Profit Margin Count0.0%
Gross Margin46.7%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 405,760
Revenue Per Share$ 0.018
Revenue (3 Years)$ 39.74
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity17.00
Int Coverage-50.80
Current Ratio85.10
Leverage Ratio1.00
Quick Ratio84.50
Long Term Debt To Capital0.90
VALUATION MEASURES
PE Ratio1.80
Enterprise Value$ 25,476,597
Price to Sales63.177
Price to Free Cash-8.50
PE High Last 5 Years-0.80
Price To Book0.60
Price To Cash Flow0.00
PE Low Last 5 Years-1.00
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover90.70
Invoice Turnover1.40
Assets Turnover0.00
Return Assets-11.83
Return on Equity-13.12
Return on Capital-12.86

Sunshine Biopharma Inc. (SBFM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorB F Borgers CPA PC
CEOSteve Slilaty
Emplyoees3
Last AuditUQ
CIK0001402328
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address6500 Trans-Canada Highway
4th Floor
Pointe-Claire, QC H9R 0A5
Websitehttps://www.sunshinebiopharma.com
Facsimile+1 514 426-6101
Telephone+1 514 426-6161
Email-


Your Recent History
NASDAQ
SBFM
Sunshine B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.